Clinical trial

Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)

NCT02005757

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-11-01

PhasePHASE2

Study timeline

Study start (unknown)2013-11-01Date precision: month

Registry last updated2015-06-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Bredinin tablet 150mgDRUG

Bredinin tablet 50mgDRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Mapped research locations

SeoulSouth Korea2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02005757 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.